September 18, 2019 โ AstraZeneca announced the U.S. Food and Drug Administration (FDA) has granted Fast Track ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
September 18, 2019
September 11, 2019 โ The angiotensin neprilysin inhibitor sacubitril/valsartan (Entresto) missed its primary endpoint of ...
September 11, 2019
September 10,2019 โ The combination of ticagrelor and aspirin reduces ischemic events compared with aspirin alone in ...
September 10, 2019
September 9, 2019 โ Prasugrel is superior to ticagrelor for reducing ischemic events in patients with acute coronary ...
September 09, 2019
September 9, 2019 โ AstraZeneca announced detailed results from the landmark Phase III DAPA-HF trial that showed Farxiga ...
September 09, 2019
September 9, 2019 โ The drug Dapagliflozin was found to reduce death and hospitalization in patients who have heart ...
September 09, 2019
September 4, 2019 โ Novartis announced results from two new clinical trials evaluating improvement in heart structure ...
September 04, 2019
August 27, 2019 โ Imagine there were a drug that you could take soon after a heart attack that could reduce damage by ...
August 27, 2019
August 23, 2019 โ Patients with peripheral artery disease (PAD) were significantly less likely to face amputation after ...
August 23, 2019
July 31, 2019 โ Researchers found anti-inflammatory drug therapies used to treat moderate to severe psoriasis can ...
July 31, 2019
July 29, 2019 โ Cancer patients taking cholesterol-lowering statin medication following radiation therapy of the chest ...
July 29, 2019
July 26, 2019 โ A new article published in AACN Advanced Critical Care outlines the traditional anticoagulant therapies ...
July 26, 2019
Sanjaya Gupta, M.D., electrophysiologist, St. Luke's Mid America Heart Institute, and assistant professor, University of ...
June 21, 2019
June 17, 2019 โ Initial results from the AVIATOR 2 international registry were presented as late-breaking clinical ...
June 17, 2019
June 14, 2019 โ Quantum Genomics announced the enrollment of the first patient in its QUORUM Phase IIb study of its lead ...
June 14, 2019ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now